<scp>GATA3</scp> as a Prognostic Marker in Early‐Stage Classical Mycosis Fungoides: Association With Disease Progression and Survival Outcomes
High GATA3 expression is an independent adverse prognostic biomarker in early-stage CMF. Incorporating GATA3 into risk stratification models may improve prognostic accuracy and guide personalized treatment strategies.
Authors
- Yao Xie
- Wei Chen (ORCID: https://orcid.org/0000-0003-0903-7945)
- Fan Li (ORCID: https://orcid.org/0000-0001-6319-8868)
- Tingting Wang (ORCID: https://orcid.org/0000-0001-9823-5059)
- Lin Wang
- Pengfei Wen (ORCID: https://orcid.org/0000-0002-9259-8083)
- Xiaoxue Zhuo
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-08-26
- DOI
- https://doi.org/10.1002/cam4.71151
- Citations
- 1
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 2.00